{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:05:39Z","timestamp":1779195939560,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jaad.2026.02.009","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:30:18Z","timestamp":1770424218000},"page":"1671-1678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hyperkalemia incidence in females over 45 years old on spironolactone for dermatologic conditions: A retrospective cohort study"],"prefix":"10.1016","volume":"94","author":[{"given":"Samantha","family":"Gregoire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza","family":"Dewey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Biba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry","family":"Ershadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debby","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Acevedo-Fontanez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Bensellam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Mostaghimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2026.02.009_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2023.12.017","article-title":"Guidelines of care for the management of acne vulgaris","volume":"90","author":"Reynolds","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2026.02.009_bib2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/ced.14340","article-title":"Spironolactone in dermatology: uses in acne and beyond","volume":"45","author":"Searle","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.02.009_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the randomized aldactone evaluation study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jaad.2026.02.009_bib5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jamadermatol.2015.34","article-title":"Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne","volume":"151","author":"Plovanich","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.02.009_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijwd.2019.04.024","article-title":"Hyperkalemia in women with acne exposed to oral spironolactone: a retrospective study from the RADAR (Research on Adverse Drug events and Reports) program","volume":"5","author":"Thiede","year":"2019","journal-title":"Int J Womens Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.02.009_bib7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaad.2022.01.010","article-title":"The need for potassium monitoring in women on spironolactone for dermatologic conditions","volume":"87","author":"Plante","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2026.02.009_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40257-016-0245-x","article-title":"Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review","volume":"18","author":"Layton","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.02.009_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijwd.2020.05.002","article-title":"Retrospective analysis of adverse events with spironolactone in females reported to the United States food and drug administration","volume":"6","author":"Wang","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jaad.2026.02.009_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.25259\/IJDVL_1280_2023","article-title":"Frequent potassium monitoring is associated with hyperkalemia that is clinically insignificant in females taking spironolactone for dermatologic conditions","volume":"90","author":"Hill","year":"2024","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"10.1016\/j.jaad.2026.02.009_bib11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1046\/j.1523-1755.2003.00207.x","article-title":"Determinants of glomerular hypofiltration in aging humans","volume":"64","author":"Hoang","year":"2003","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.jaad.2026.02.009_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/bjd\/ljac068","article-title":"Retrospective analysis of the risk of hyperkalaemia in women older than 65 years of age prescribed spironolactone for female-pattern hair loss","volume":"188","author":"Collins","year":"2023","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2026.02.009_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/jwh.2010.2722","article-title":"Acne vulgaris in women: prevalence across the life span","volume":"21","author":"Perkins","year":"2012","journal-title":"J Womens Health 2002"},{"issue":"1","key":"10.1016\/j.jaad.2026.02.009_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2007.06.045","article-title":"The prevalence of acne in adults 20 years and older","volume":"58","author":"Collier","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.02.009_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jaad.2024.07.1446","article-title":"Timing of potassium monitoring in females treated for acne with spironolactone is not optimal: a retrospective cohort study","volume":"91","author":"Lai","year":"2024","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226001726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226001726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:06:04Z","timestamp":1779192364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226001726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0190962226001726"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.02.009","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperkalemia incidence in females over 45 years old on spironolactone for dermatologic conditions: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}